Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Cytek Biosciences (CTKB) Leases (2022 - 2025)

Cytek Biosciences' Leases history spans 4 years, with the latest figure at $11.3 million for Q4 2025.

  • For Q4 2025, Leases rose 11.28% year-over-year to $11.3 million; the TTM value through Dec 2025 reached $11.3 million, up 11.28%, while the annual FY2025 figure was $11.3 million, 11.28% up from the prior year.
  • Leases reached $11.3 million in Q4 2025 per CTKB's latest filing, up from $11.2 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $16.4 million in Q2 2025 to a low of $9.3 million in Q2 2024.
  • Average Leases over 4 years is $12.0 million, with a median of $11.5 million recorded in 2023.
  • Peak YoY movement for Leases: dropped 24.91% in 2024, then surged 75.68% in 2025.
  • A 4-year view of Leases shows it stood at $13.9 million in 2022, then dropped by 21.83% to $10.9 million in 2023, then fell by 6.31% to $10.2 million in 2024, then increased by 11.28% to $11.3 million in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Leases are $11.3 million (Q4 2025), $11.2 million (Q3 2025), and $16.4 million (Q2 2025).